Valuation: Ginwa Enterprise (Group) Inc.

Market Cap 1.6B 236M 208M 193M 178M 333M 22.89B 339M 2.31B 901M 11.17B 888M 868M 38.74B P/E 2024
37.4x
P/E 2025 171x
Enterprise Value 1.25B 184M 162M 150M 138M 260M 17.83B 264M 1.8B 702M 8.7B 691M 676M 30.18B EV / Sales 2024
4.15x
EV / Sales 2025 4.24x
Free-Float
66.46%
Yield 2024
0.38%
Yield 2025 0.4%
1 day+2.89%
1 week-8.86%
Current month+3.58%
1 month-2.94%
3 months-41.61%
6 months-42.77%
Current year-38.59%
1 week 4.38
Extreme 4.38
4.85
1 month 4.26
Extreme 4.26
5.18
Current year 4.26
Extreme 4.26
9.3
1 year 4.26
Extreme 4.26
9.35
3 years 4.26
Extreme 4.26
9.35
5 years 4.26
Extreme 4.26
10.97
10 years 3.7
Extreme 3.7
14.93
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-28
Director of Finance/CFO 44 2025-04-09
Corporate Officer/Principal 30 2022-02-15
Director TitleAgeSince
Director/Board Member 63 2011-04-20
Director/Board Member 53 2022-03-03
Chairman 55 2020-06-28
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%-8.86%-38.68%-38.84% 241M
+0.85%+1.99%+49.31%+161.81% 1,057B
+1.34%+3.89%+55.05%+53.67% 624B
+0.73%+1.96%+35.97%+81.23% 454B
+1.16%+6.55%+34.33%+30.20% 341B
-1.01%+1.81%+36.06%+40.15% 297B
-0.10%+1.18%+16.83%+18.20% 262B
+0.50%-1.73%-27.48%-41.05% 215B
+1.45%+3.27%+22.59%+60.68% 201B
-0.50%-2.99%+15.08%+67.74% 162B
Average +0.75%+0.51%+19.91%+43.38% 361.42B
Weighted average by Cap. +0.70%+1.57%+36.16%+78.24%

Financials

2024 2025
Net sales 585M 86.43M 76.02M 70.62M 64.95M 122M 8.37B 124M 844M 329M 4.08B 324M 317M 14.16B 544M 80.32M 70.64M 65.62M 60.35M 113M 7.78B 115M 785M 306M 3.79B 302M 295M 13.16B
Net income 74.61M 11.01M 9.69M 9M 8.28M 15.52M 1.07B 15.8M 108M 41.98M 520M 41.35M 40.46M 1.81B 15.58M 2.3M 2.02M 1.88M 1.73M 3.24M 223M 3.3M 22.47M 8.76M 109M 8.63M 8.45M 377M
Net Debt -327M -48.2M -42.39M -39.38M -36.22M -67.93M -4.67B -69.15M -471M -184M -2.28B -181M -177M -7.9B -354M -52.26M -45.96M -42.7M -39.27M -73.64M -5.06B -74.96M -511M -199M -2.47B -196M -192M -8.56B
Logo Ginwa Enterprise (Group) Inc.
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Employees
613
Date Price Change Volume
26-07-24 CN¥4.540 -1.94% 2,227,500
26-07-23 CN¥4.630 +2.89% 1,606,100
26-07-22 CN¥4.500 -1.10% 1,673,800
26-07-21 CN¥4.550 -1.09% 3,125,546
26-07-20 CN¥4.600 -2.54% 3,171,300
  1. Stock Market
  2. Stocks
  3. 600080 Stock